Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-02-25 @ 7:21 PM
Study NCT ID:
NCT06069869
Status:
RECRUITING
Last Update Posted:
2025-10-02
First Post:
2023-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
Sponsor:
George Washington University
Organization:
Study Overview
Official Title:
Individually Randomized Crossover Trial of Multiple Micronutrient Supplementation (MMS) Iron Dosages During Pregnancy in Tanzania
Status:
RECRUITING
Status Verified Date:
2025-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MID-ACT
Brief Summary:
This is an individually randomized cross-over trial to assess acceptability, preference, and perceived side effects of MMS formulations with 30 mg, 45 mg and 60 mg of iron.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: